AU2003267581A1 - Drug delivery - Google Patents

Drug delivery

Info

Publication number
AU2003267581A1
AU2003267581A1 AU2003267581A AU2003267581A AU2003267581A1 AU 2003267581 A1 AU2003267581 A1 AU 2003267581A1 AU 2003267581 A AU2003267581 A AU 2003267581A AU 2003267581 A AU2003267581 A AU 2003267581A AU 2003267581 A1 AU2003267581 A1 AU 2003267581A1
Authority
AU
Australia
Prior art keywords
drug delivery
relates
delivery
drugs
solubilising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267581A
Other languages
English (en)
Other versions
AU2003267581A8 (en
Inventor
Woei Ping Cheng
Andreas Schatzlein
Ijeoma Uchegbu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Publication of AU2003267581A1 publication Critical patent/AU2003267581A1/en
Publication of AU2003267581A8 publication Critical patent/AU2003267581A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C08G73/0226—Quaternisation of polyalkylene(poly)amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003267581A 2002-09-20 2003-09-22 Drug delivery Abandoned AU2003267581A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery
GB0221942.6 2002-09-20
PCT/GB2003/004036 WO2004026941A1 (en) 2002-09-20 2003-09-22 Drug delivery

Publications (2)

Publication Number Publication Date
AU2003267581A1 true AU2003267581A1 (en) 2004-04-08
AU2003267581A8 AU2003267581A8 (en) 2004-04-08

Family

ID=9944516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267581A Abandoned AU2003267581A1 (en) 2002-09-20 2003-09-22 Drug delivery

Country Status (11)

Country Link
US (1) US20060148982A1 (enExample)
EP (1) EP1543063B1 (enExample)
JP (1) JP2006500437A (enExample)
AT (1) ATE426635T1 (enExample)
AU (1) AU2003267581A1 (enExample)
CA (1) CA2499681A1 (enExample)
DE (1) DE60326859D1 (enExample)
DK (1) DK1543063T3 (enExample)
GB (1) GB0221942D0 (enExample)
SI (1) SI1543063T1 (enExample)
WO (1) WO2004026941A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422877D0 (en) * 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
DK1979407T5 (en) 2006-01-19 2014-12-01 Allexcel Inc Solubilization and targeted delivery of drugs with self-forming amphiphilic polymers
CA2636739A1 (en) * 2006-01-27 2007-08-02 Ciba Holding Inc. Polymeric anti-microbial agents
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US20090246155A1 (en) * 2006-12-05 2009-10-01 Landec Corporation Compositions and methods for personal care
US20090263346A1 (en) * 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
AU2007328207A1 (en) * 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US20100004124A1 (en) * 2006-12-05 2010-01-07 David Taft Systems and methods for delivery of materials for agriculture and aquaculture
JP2010513644A (ja) * 2006-12-22 2010-04-30 ビーエーエスエフ ソシエタス・ヨーロピア 移染防止剤としての疎水性に変性されたポリアルキレンイミン
MX341715B (es) * 2007-07-19 2016-08-23 Allexcel Inc Polímeros anfifílicos de autoensamblaje como agentes anticáncer.
US8114883B2 (en) * 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
GB0903559D0 (en) 2009-03-02 2009-04-08 Univ London Pharmacy Oral delivery of hydrophilic drugs to the brain
CN105214143A (zh) 2009-04-28 2016-01-06 苏尔莫迪克斯公司 用于递送生物活性剂的装置和方法
GB0915449D0 (en) 2009-09-04 2009-10-07 Univ Robert Gordon Composition
DK2563843T3 (en) * 2010-04-28 2018-03-12 Univ Georgia PHOTOCHEMICAL CROSS-POLYMERS, PROCEDURES FOR MARKING PHOTOCHEMIC CROSS-POLYMERS, PROCEDURES FOR USING PHOTOCHEMIC CROSS-POLYMERS, AND ...
US8721936B2 (en) 2011-04-21 2014-05-13 University Of Georgia Research Foundation, Inc. Devices and methods for forming non-spherical particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
EP2731999A4 (en) 2011-07-15 2015-09-23 Univ Georgia PERMANENT FIXING OF MEANS OF SURFACES WITH C-H FUNCTIONALITY
WO2013019918A2 (en) 2011-08-04 2013-02-07 The University Of Georgia Research Foundation, Inc. Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality
WO2013056007A2 (en) 2011-10-14 2013-04-18 University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable plolymers, methods of using photochemical cross-linkable poloymers, and methods of making articles containing photochemical cross-linkable polymers
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
US9555119B2 (en) 2012-11-05 2017-01-31 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
US12226552B2 (en) 2019-09-30 2025-02-18 Surmodics, Inc. Active agent depots formed in situ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
JPH01236240A (ja) * 1989-01-14 1989-09-21 Miyoshi Oil & Fat Co Ltd 新規な高分子化合物
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
JP3406970B2 (ja) * 1993-12-27 2003-05-19 ミヨシ油脂株式会社 両性界面活性剤
JP3526661B2 (ja) * 1995-06-23 2004-05-17 ミヨシ油脂株式会社 抗菌剤、抗菌性樹脂及び抗菌性塗料
WO1997048673A1 (en) * 1996-06-19 1997-12-24 The Procter & Gamble Company Process for removing malodors from modified polyamines
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
CN1479632A (zh) * 2000-10-09 2004-03-03 拜尔公司 用于将核酸导入细胞的复合物
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps

Also Published As

Publication number Publication date
US20060148982A1 (en) 2006-07-06
SI1543063T1 (sl) 2009-08-31
EP1543063A1 (en) 2005-06-22
GB0221942D0 (en) 2002-10-30
DK1543063T3 (da) 2009-05-18
DE60326859D1 (de) 2009-05-07
JP2006500437A (ja) 2006-01-05
CA2499681A1 (en) 2004-04-01
ATE426635T1 (de) 2009-04-15
WO2004026941A1 (en) 2004-04-01
AU2003267581A8 (en) 2004-04-08
EP1543063B1 (en) 2009-03-25

Similar Documents

Publication Publication Date Title
AU2003267581A1 (en) Drug delivery
WO2003011226A3 (en) Products and drug delivery vehicles
WO2004011611A3 (en) Taci antibodies and uses thereof
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
TW200616589A (en) Transdermal delivery of drugs based on crystal size
WO2008101214A3 (en) Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
WO2003090696A3 (en) Methods and products for mucosal delivery
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
EP1783137A4 (en) GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
WO2006124681A3 (en) Oral drug delivery system and methods of use thereof
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2005041936A3 (en) Methods of treatment of cancer using a composition comprising a cytotoxic drug and a porous carrier material
AU2003272260A1 (en) Verifiable absorption drug delivery form based on cyclodextrins
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
WO2005041881A3 (en) Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
WO2004018010A3 (en) Methods of drug delivery using sulphated chitinous polymers
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
WO2006107806A3 (en) Stannsoporfin compositions and administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase